Twelve chemicals were associated with increased breast cancer risk. Heterozygosity in BRCA1 genes is not enough to prevent tumor proliferation, according to researchers out of Harvard. Thyroid and parathyroid dysfunction is common among women with breast cancer following radiotherapy. A study aimed to assess TILs as predictors of response to neoadjuvant chemotherapy in locally advanced breast cancer. Researchers designed a interpretable deep learning model for detecting BRCA pathogenic variants of breast cancer. A novel method can assess which patients with TNBC could benefit from immunotherapy. This could be a needed breakthrough for those predisposed to breast and ovarian cancer mutations. BUB1 has potential prognostic value in therapy decision-making across breast cancer characterizations. New research shows that selenium, a mineral commonly found in Brazil nuts, could hold the key to stopping the spread of TNBC. Cancer researchers at Brigham and Women’s Hospital have identified a potential new method for the treatment of TNBC. YouTube content around breast cancer is mainly beneficial and empowering for people coping with their diagnosis. Two UCF researchers were bestowed state grants to support their innovative projects to fight breast cancer. Dr. Sadie Dobrozsi spoke on the importance of genetic testing in breast cancer to better understand the disease. Cancer incidence trends in 2021 mostly returned to their pre-COVID-19 pandemic levels, with the exception of breast cancer. A study analyzed the correlation between cancer-related cognitive impairment and neurotransmission pathways. A new study finds that 3D digital breast tomosynthesis is more effective at detecting BC than traditional 2D. Two international studies show that women who breastfeed following BC treatment do not have an increased risk of BC. New research suggests ICI therapy improves efficacy outcomes in early-stage breast cancer over adjuvant therapy. Researchers identified immune system white blood cells that appear closely related to BC cells that are likely to spread. Women who receive false-positive mammogram results are less likely to return for a follow-up screening.